{
    "Trade/Device Name(s)": [
        "LIAISON Calprotectin",
        "LIAISON Calprotectin Control Set",
        "LIAISON Calprotectin Calibration Verifiers",
        "LIAISON Q.S.E.T. Buffer",
        "LIAISON Q.S.E.T. Device"
    ],
    "Submitter Information": "DiaSorin Inc.",
    "510(k) Number": "K182698",
    "Predicate Device Reference 510(k) Number(s)": [
        "DEN060001",
        "K141463"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NXO",
        "JJX"
    ],
    "Summary Letter Date": "September 26, 2018",
    "Summary Letter Received Date": "September 27, 2018",
    "Submission Date": "September 27, 2018",
    "Regulation Number(s)": [
        "21 CFR 866.5180",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Fecal calprotectin immunological test system",
        "Single (Specified) analyte controls (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "immunology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Calprotectin"
    ],
    "Specimen Type(s)": [
        "Stool"
    ],
    "Specimen Container(s)": [
        "LIAISON Q.S.E.T. Device",
        "Standard collection container (for manual extraction)"
    ],
    "Instrument(s)/Platform(s)": [
        "LIAISON XL Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay (CLIA)",
        "Solid phase immunoassay"
    ],
    "Methodologies": [
        "Sandwich immunoassay",
        "Automated immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Calibration verifier",
        "Buffer",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for DiaSorin LIAISON Calprotectin chemiluminescent immunoassay and associated controls and devices for quantitation of fecal calprotectin on the LIAISON XL Analyzer.",
    "Indications for Use Summary": "Quantitative measurement of fecal calprotectin in human stool as an aid in the diagnosis of inflammatory bowel diseases (IBD), specifically Crohn\u2019s disease and ulcerative colitis, and to differentiate IBD from irritable bowel syndrome (IBS); used with LIAISON XL Analyzer.",
    "fda_folder": "Immunology"
}